Nomura Asset Management CO LTD Amgen Inc Transaction History

Nomura Asset Management CO LTD

$37.3 Billion
Q3 2025

A detailed history of Nomura Asset Management CO LTD transactions in Amgen Inc stock. As of the latest transaction made, Nomura Asset Management CO LTD holds 309,214 shares of AMGN stock, worth $106 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

309,214

Previous 335,745 7.9%

Holding current value

$106 Million

Previous $93.7 Million 6.92%

% of portfolio

0.23%

Previous 0.26%

44 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$271.18 - $309.22 $7.19 Million - $8.2 Million	-26,531 Reduced 7.9%	309,214 $87.3 Million
Q2 2025 Aug 11, 2025	SELL	$262.28 - $309.85 $832,476 - $983,463	-3,174 Reduced 0.94%	335,745 $93.7 Million
Q1 2025 May 12, 2025	BUY	$258.59 - $327.36 $101,884 - $128,979	394 Added 0.12%	338,919 $106 Million
Q4 2024 Feb 12, 2025	SELL	$258.78 - $328.31 $448,206 - $568,632	-1,732 Reduced 0.51%	338,525 $88.2 Million
Q3 2024 Nov 15, 2024	BUY	$309.38 - $337.38 $3.51 Million - $3.83 Million	11,348 Added 3.45%	340,257 $110 Million

Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $4.8 Million - $5.84 Million	-18,279 Reduced 5.26%	328,909 $103 Million
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $9.16 Million - $11.1 Million	-34,074 Reduced 8.94%	347,188 $98.7 Million
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $1.31 Million - $1.48 Million	5,125 Added 1.36%	381,262 $110 Million
Q3 2023 Nov 03, 2023	SELL	$218.65 - $271.46 $2.26 Million - $2.81 Million	-10,341 Reduced 2.68%	376,137 $101 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $19.2 Million - $22.6 Million	89,376 Added 30.08%	386,478 $85.8 Million
Q1 2023 Jan 10, 2025	SELL	$225.79 - $275.2 $28.7 Million - $34.9 Million	-126,930 Reduced 29.93%	297,102 $71.8 Million
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $28.7 Million - $34.9 Million	-126,930 Reduced 29.93%	297,102 $71.8 Million
Q4 2022 Jan 10, 2025	SELL	$229.03 - $291.01 $9.07 Million - $11.5 Million	-39,597 Reduced 8.54%	424,032 $111 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $9.07 Million - $11.5 Million	-39,597 Reduced 8.54%	424,032 $111 Million
Q3 2022 Jan 10, 2025	SELL	$224.46 - $253.15 $3.2 Million - $3.61 Million	-14,242 Reduced 2.98%	463,629 $105 Million
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $3.2 Million - $3.61 Million	-14,242 Reduced 2.98%	463,629 $105 Million
Q2 2022 Jan 10, 2025	SELL	$230.71 - $256.74 $2.79 Million - $3.11 Million	-12,098 Reduced 2.47%	477,871 $116 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $2.79 Million - $3.11 Million	-12,098 Reduced 2.47%	477,871 $116 Million
Q1 2022 Jan 10, 2025	BUY	$219.27 - $242.57 $32.8 Million - $36.3 Million	149,712 Added 44.0%	489,969 $118 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $18.9 Million - $20.9 Million	-86,364 Reduced 14.99%	489,969 $118 Million
Q4 2021 Jan 10, 2025	BUY	$198.88 - $227.6 $22.2 Million - $25.4 Million	111,787 Added 24.06%	576,333 $130 Million
Q4 2021 Feb 01, 2022	BUY	$198.88 - $227.6 $22.2 Million - $25.4 Million	111,787 Added 24.06%	576,333 $130 Million
Q3 2021 Jan 10, 2025	BUY	$212.27 - $248.7 $11.1 Million - $13 Million	52,199 Added 12.66%	464,546 $98.8 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $11.1 Million - $13 Million	52,199 Added 12.66%	464,546 $98.8 Million
Q2 2021 Jan 10, 2025	BUY	$233.58 - $259.14 $5.75 Million - $6.37 Million	24,596 Added 6.34%	412,347 $101 Million
Q2 2021 Aug 06, 2021	BUY	$233.58 - $259.14 $5.75 Million - $6.37 Million	24,596 Added 6.34%	412,347 $101 Million
Q1 2021 Jan 10, 2025	BUY	$221.91 - $258.6 $10.5 Million - $12.3 Million	47,494 Added 13.96%	387,751 $96.5 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $2.11 Million - $2.46 Million	-9,516 Reduced 2.4%	387,751 $96.5 Million
Q4 2020 Jan 10, 2025	BUY	$216.38 - $257.67 $12.3 Million - $14.7 Million	57,010 Added 16.75%	397,267 $91.3 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $2.24 Million - $2.66 Million	10,341 Added 2.67%	397,267 $91.3 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $3.63 Million - $4.04 Million	-15,465 Reduced 3.84%	386,926 $98.3 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $397,795 - $488,150	2,011 Added 0.5%	402,391 $94.9 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $2.8 Million - $3.71 Million	-15,360 Reduced 3.69%	400,380 $81.2 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $2.55 Million - $3.28 Million	-13,501 Reduced 3.15%	415,740 $100 Million
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $8.02 Million - $9.61 Million	46,066 Added 12.02%	429,241 $83.1 Million
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $32 Million - $37.5 Million	-191,979 Reduced 33.38%	383,175 $70.6 Million
Q1 2019 May 10, 2019	BUY	$180.87 - $203.88 $446,929 - $503,787	2,471 Added 0.43%	575,154 $109 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $1.13 Million - $1.32 Million	6,333 Added 1.12%	572,683 $111 Million
Q3 2018 Nov 07, 2018	SELL	$185.29 - $208.89 $2.31 Million - $2.6 Million	-12,445 Reduced 2.15%	566,350 $117 Million
Q2 2018 Aug 03, 2018	SELL	$166.05 - $186.51 $328,446 - $368,916	-1,978 Reduced 0.34%	578,795 $107 Million
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $3.49 Million - $4.08 Million	20,611 Added 3.68%	580,773 $99 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $3.85 Million - $4.3 Million	22,790 Added 4.24%	560,162 $97.4 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $7.23 Million - $8.25 Million	43,205 Added 8.74%	537,372 $100 Million
Q2 2017 Aug 14, 2017	BUY	N/A	494,167	494,167 $85.1 Million

Others Institutions Holding AMGN

# of Institutions

3,273

Shares Held

428M

Call Options Held

6.11M

Put Options Held

5.85M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $183B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.

Account

Nomura Asset Management CO LTD Amgen Inc Transaction History